Mako Surgical Corp. - Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Expires: January 31, 2008 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Blumenfeld S Morry

2. Date of Event Requiring Statement (MM/DD/YYYY) 2/14/2008

3. Issuer Name and Ticker or Trading Symbol

MAKO Surgical Corp. [MAKO]

(Last) (First) (Middle)

504 GRAND STREET, APARTMENT E-31

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)

(Street)

NEW YORK, NY 10002

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Series B Convertible Preferred Stock	7/14/2005	⁽¹⁾	Common Stock	125012 ⁽¹⁾	⁽¹⁾	I	By Meditech Advisors LLC ⁽²⁾
Series C Convertible Preferred Stock	2/6/2007	⁽¹⁾	Common Stock	9371 ⁽¹⁾	⁽¹⁾	I	By Meditech Advisors LLC ⁽²⁾
Series C Convertible Preferred Stock	2/6/2007	⁽¹⁾	Common Stock	488509 ⁽¹⁾	⁽¹⁾	I	By Ziegler Meditech Equity Partners, L.P. ⁽³⁾

Explanation of Responses:
( 1)	The convertible preferred stock has no expiration date. As a result of a one-for-3.03 reverse split of MAKO Surgical Corp. common stock, each share of convertible preferred stock is convertible into .330033 of a share of common stock. Accordingly, upon the closing of the issuer's initial public offering, the convertible preferred stock will convert into the number of shares of common stock set forth in Column 3.
( 2)	The shares are owned by Meditech Advisors LLC, the partners of which are Eitan Machover, Samuel Cubac, Grosvenor LLC and Allandale Ltd. The reporting person and certain of his family members constitute the members of Grosvenor LLC, but he disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
( 3)	The reporting person is a member of the board of managers of Ziegler Meditech Partners, LLC, the general partner of Ziegler Meditech Equity Partners, L.P., but he disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.

Remarks:
Exhibit List
Exhibit 24 - Power of Attorney

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Blumenfeld S Morry 504 GRAND STREET APARTMENT E-31 NEW YORK, NY 10002	X

Signatures
/s/ Menashe R. Frank, attorney in fact		2/14/2008
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.